Andrew Scott Smith
Affiliations
- at Bioatla Inc. (BCAB), 2025-06-18
- Chief Executive Officer at Viatris Inc (VTRS), 2025-05-14
- Director at Apexigen Inc. (APGN), 2023-08-25
- Director at Spring Bank Pharmaceuticals Inc. (SBPH), 2020-06-25
- See Remarks at Celgene Corp (CELG), 2018-02-20
- Director at Titan Pharmaceuticals Inc (TTNP), 2017-09-19
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| VTRS | $8.94 | 60,000 | $536,262.00 | 292,807 | 2025-05-12 | Filing |
| SBPH | $4.09 | 12,000 | $49,080.00 | 13,883 | 2019-06-28 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BCAB | $22.47 | 59 | $1,325.79 | 345,656 | 2021-12-02 | Filing |
| BCAB | $21.74 | 2,925 | $63,592.43 | 345,715 | 2021-12-02 | Filing |
| BCAB | $24.22 | 76 | $1,841.02 | 348,640 | 2021-12-01 | Filing |
| BCAB | $23.27 | 350 | $8,143.10 | 348,716 | 2021-12-01 | Filing |
| BCAB | $22.19 | 202 | $4,481.57 | 349,066 | 2021-12-01 | Filing |